North America holds a leading revenue share in the global chondroitin sulfate market. The region benefits from advanced pharmaceutical manufacturing, widespread insurance coverage for ophthalmic surgical procedures, and a strong culture of wellness and active lifestyle management among older demographics. Key players across the US and Canada are actively investing in multi-ingredient joint...